SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-19-013653
Filing Date
2019-11-07
Accepted
2019-11-07 16:06:32
Documents
19
Period of Report
2019-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K q319epr8k.htm   iXBRL 8-K 40949
2 EXHIBIT 99.1 bold20191107ex991.htm EX-99.1 15870
8 bold20191107ex991001.jpg GRAPHIC 203853
9 bold20191107ex991002.jpg GRAPHIC 220841
10 bold20191107ex991003.jpg GRAPHIC 263381
11 bold20191107ex991004.jpg GRAPHIC 115500
  Complete submission text file 0001628280-19-013653.txt   1313116

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bold-20191107.xsd EX-101.SCH 4588
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bold-20191107_cal.xml EX-101.CAL 624
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bold-20191107_def.xml EX-101.DEF 1474
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bold-20191107_lab.xml EX-101.LAB 26142
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bold-20191107_pre.xml EX-101.PRE 13580
17 EXTRACTED XBRL INSTANCE DOCUMENT q319epr8k_htm.xml XML 4446
Mailing Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108
Business Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108 415-638-6556
Audentes Therapeutics, Inc. (Filer) CIK: 0001628738 (see all company filings)

IRS No.: 461606174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37833 | Film No.: 191200309
SIC: 2836 Biological Products, (No Diagnostic Substances)